Brad Burton, PharmD, An Experienced Oncology Pharmacist and Patient Safety Advocate, Explores the Importance of Maintaining Up-to-Date Medication Histories in order to Reduce Medication Errors and Improve Patient Outcomes
Denver, Colorado, 21st May 2023, ZEX PR WIRE, In a recent interview, Dr. Brad Burton, an oncology pharmacist whose experience spans over 15 years, shared his perspectives regarding the importance of maintaining an accurate and complete list of medications (including complementary and alternative products). Burton notes that allowing for extra time and attention to the patient-provider interaction plays a pivotal role in reducing medication errors and enhancing patient safety in the fast-paced and ever-evolving healthcare field. These risks are even higher in an oncology patient because of the complexity of regimens administered, drug interactions, unique toxicity profiles associated with novel agents, and the presence of other chronic comorbidities.
Burton commented that medication errors can have severe consequences, including prolonged hospital stays, increased healthcare costs, and even loss of life. He notes that these consequences are of special importance in older adults, as this demographic generally takes more medications than other age groups. Another key consideration that Burton points out is over the counter (OTC) medications. Although these medications can be obtained without a prescription, Burton underscores the importance of inquiring specifically about this class of medications during every patient interview as these agents may be perceived as carrying less severe safety and/or drug interaction risks than agents dispensed via prescription.
According to Burton, pharmacists are often viewed by patient care teams as the medication experts, and therefore play a critical role in ensuring accurate and current medication histories. He also believes that the responsibility can and should be shared across the team, to ensure that patients are kept safe from medication errors. Moreover, Burton added that up-to-date medication histories promote seamless communication and collaboration among healthcare providers. When health care providers can access accurate and current information, they can coordinate care more efficiently, leading to a more cohesive and integrated healthcare system. Burton notes that this is crucial for cancer patients where care decisions oftentimes involve members of multiple disciplines, including radiation oncology, dietitians, and palliative care specialists to name a few. When teams are communicating closely about medication recommendations and updates, the likelihood of therapeutic duplication and other medication-related problems is reduced and the risk of complications and consequences previously described is minimized, thereby enhancing patient safety throughout the care continuum.
Burton also noted that in the digital age, the transition from paper-based records to electronic health records (EHRs) has further amplified the significance of up-to-date medication histories. He noted that EHR systems facilitate real-time access to patient data, enable automatic alerts for allergies or drug interactions, and enhance data accuracy through standardized documentation practices. Burton also said that EHRs support data analysis and allow healthcare organizations to identify patterns, trends, and potential risks to patient safety, thereby driving continuous quality improvement.
Burton remains committed to promoting patient safety through emphasizing the importance of up-to-date medication histories as a cornerstone of patient-centered care. Throughout his career, he has been heavily involved in conducting medication histories, communicating its importance to patient care teams, and working with other disciplines within the health care delivery system to optimize their management and utilization. To quote Burton,
“As we embrace the digital era, the significance of up-to-date medication histories cannot be overstated. By prioritizing accurate and current patient information, healthcare organizations can reduce medical errors, enhance patient safety, and save lives.”
Brad Burton, PharmD is an Associate Director, Oncology Patient Safety Scientist at AstraZeneca where he works with a team of pharmacovigilance scientists and physicians supporting risk management planning for investigational cancer products. Before joining AstraZeneca, Burton worked at Johns Hopkins Hospital for 13 years, as a clinical pharmacy specialist focusing on the management of solid tumors and associated supportive care needs in both inpatient and outpatient settings. Besides his stellar career, Burton is passionate about the education and training of pharmacists and other health care professionals, and he holds multiple certifications, including Good Pharmacovigilance Practice (GVP), ACCP: Precision Medicine – Oncology Genomics, and Board-Certified Oncology Pharmacist (BCOP) through the Board of Pharmacy Specialties.
DISCLAIMER: Dr. Burton contributed to this press release in his personal capacity. The views expressed are his own and do not necessarily represent the views of AstraZeneca or Johns Hopkins Hospital or any of its subsidiaries or affiliates.
ZEX PR Wire offers massive Press Release, News, Authored Articles, Editorial services, geared at generating massive exposure for your unique project, business, or concept.
ZEX PR WIRE is a premium press release distribution provides end-to- end solutions to produce, optimize and target content and then distribute and measure results. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, ZEX PR WIRE serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and Asia-Pacific regions.
Disclaimer: ZEXPRWIRE is a newswire distribution network. Articles and other content published by ZEXPRWIRE are the legal responsibility of the author and ZEXPRWIRE accepts no liability for the content of such material. ZEXPRWIRE publishes content for informational purposes and makes no representations regarding, recommendation or invitation to engage in, any form of financial or investment activity, and does not endorse the content of any material published.
ZEX PR WIRE allows users to submit their press releases through our online platform. Once submitted, our team reviews the content for quality and relevance. Upon approval, the press release is distributed to our extensive network, including major news outlets, industry-specific publications, and online platforms.
You can streamline the distribution process while still benefiting from human oversight. This ensures that your press releases meet quality standards, increasing the likelihood of media coverage and enhancing your brand's visibility.
ZEX PR WIRE accepts a wide range of press releases, including product launches, company announcements, event promotions, new partnerships, industry insights, and more. However, we do not accept press releases containing offensive or illegal content. For more information on this please visit https://zexprwire.com/editorial-guidelines/
Pricing for using ZEX PR WIRE varies depending on the distribution package you choose. We offer different plans to suit various needs and budgets. For detailed pricing information, please visit https://pr.zexprwire.com/pricing
You can view the total number of site submissions, status for each submission (live/pending), hyperlinks for each live PR, details pertaining to your package and number of press releases remaining, and view count for each live PR through third-party tracker integrations. (You may change the content according to what we provide in analytics).
ZEX PR Wire operates between 10AM to 7PM IST. During these hours, press releases may be distributed immediately after editorial approval of the press release. Otherwise, it will be published the next day. Additionally, several publications might require more than one day to be completed.
It generally takes 24- 72 hrs to publish the press release and generate the report
Yes, ZEX PR WIRE allows you to schedule the distribution of your press release for a specific date and time. This feature enables you to plan your PR campaigns strategically and ensure that your news reaches the right audience at the right time.
If you have any further questions or need assistance, you can reach out to our customer support team through direct Whatsapp ,chat on the web or can write to us at [email protected]. We are available to help you with any queries or concerns you may have.